LetsGetChecked Acquires Veritas Genetics and Veritas Intercontinental
March 29, 2022
LetsGetChecked announced it will acquire Veritas Genetics Inc. and Veritas Intercontinental to integrate whole genome sequencing and expanded genomic services into its at‑home diagnostics and virtual care platform. The deal adds capabilities across prenatal, predictive medicine, pharmacogenomics and cancer screening and positions LetsGetChecked to expand genomic offerings internationally.
- Buyers
- LetsGetChecked
- Targets
- Veritas Genetics, Veritas Intercontinental
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
LetsGetChecked Acquires Truepill
October 1, 2024
Healthcare Services
LetsGetChecked has completed the acquisition of Truepill, a digital pharmacy platform, to integrate pharmacy technology and medication fulfillment into its at-home healthcare solutions. The deal creates a combined offering that spans testing, virtual care, and prescription delivery to support a full lifecycle of care for employers, health plans, providers, and consumer patients.
-
Veracyte to Acquire C2i Genomics to Add Whole-Genome MRD Capabilities
January 8, 2024
Healthcare Services
Veracyte has reached a definitive agreement to acquire C2i Genomics, a minimal residual disease (MRD) detection company, to add whole-genome MRD capabilities to its diagnostics platform. Under the terms, Veracyte will pay $70 million in Veracyte shares at closing and up to an additional $25 million tied to future performance milestones, expected to close in the first quarter of 2024.
-
Tesis Biosciences Acquires Genome Explorations
February 16, 2022
Biotechnology
Tesis Biosciences has acquired Genome Explorations to accelerate its clinical research and product development efforts in targeted genetic sequencing and precision medicine. The acquisition brings Genome Explorations’ genomic profiling and molecular diagnostics capabilities and clinical research staff into Tesis’ integrated platform to speed development of proprietary therapeutics and diagnostic products.
-
LetsGetChecked Acquires BioIQ
November 16, 2021
Healthcare Services
LetsGetChecked has acquired BioIQ, an analytics-driven population health and diagnostics company, with BioIQ operating as a wholly owned subsidiary. The deal expands LetsGetChecked’s at-home diagnostics, telehealth and pharmacy capabilities and broadens its reach into health plan, employer and public-sector markets.
-
Interpace Diagnostics Acquires Cancer Genetics' Biopharma Services Business
July 15, 2019
Healthcare Services
Interpace Diagnostics Group, Inc. acquired assets and certain liabilities comprising the Biopharma Services business of Cancer Genetics, Inc. for approximately $23.5 million, with the business continuing to operate from labs in Rutherford, New Jersey and Research Triangle Park, North Carolina. In conjunction with the transaction Ampersand Capital Partners invested $27 million in Interpace via convertible preferred stock to support the acquisition and Interpace’s growth in the clinical diagnostic and biopharma services markets.
-
Veritas Genetics Acquires Curoverse
August 3, 2017
Biotechnology
Veritas Genetics has acquired Boston-based Curoverse, the creator of the Arvados open-source genomic data platform, for an undisclosed amount. The acquisition brings Curoverse’s bioinformatics, data-management and AI/ML capabilities in-house to expand Veritas’s capacity for large-scale genome interpretation and deploy machine learning across millions of genomes.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.